James F. Belliveau

Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil

M. Posner, M. Wiemann, P. Calabresi, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.

M. Posner, A. Forastiere, J. Belliveau, 1988, Cancer research.

Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.

L. Ferrari, M. Posner, M. Wiemann, 1986, Cancer treatment reports.